{"id":"W2983107219","doi":"10.1177/1352458519881761","title":"Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; McGill University; NeuroRx Research (Canada)","funders":"National Center for Advancing Translational Sciences; Biogen","keywords":"Tolerability; Medicine; Dimethyl fumarate; Adverse effect; Discontinuation; Multiple sclerosis; Internal medicine; Relapsing remitting; Interim analysis; Clinical endpoint; Bioequivalence; Confidence interval; Phases of clinical research; Clinical trial; Gastroenterology; Pharmacokinetics; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004638663,0.0006626333,0.001266396,0.0002605446,0.0003778317,0.0006662999,0.0004112104,0.0007441793,0.001060307],"category_scores_gemma":[0.002294272,0.000237395,0.00106507,0.0002916021,0.0002846959,0.000670564,0.0003286134,0.001487258,0.0003442965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003500738,"about_ca_system_score_gemma":0.0005346697,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003478288,"about_ca_topic_score_gemma":0.001012826,"domain_scores_codex":[0.9991515,0.0004364351,0.00009326161,0.0000772989,0.0001603858,0.00008112893],"domain_scores_gemma":[0.9984138,0.0003627311,0.0005945814,0.0001117198,0.0002017028,0.0003153534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5602466,0.02138957,0.09210005,0.001489416,0.004131599,0.0006635328,0.0007650821,0.002271292,0.0335414,0.0002019498,0.005115108,0.2780843],"study_design_scores_gemma":[0.2311793,0.4734004,0.2641456,0.000221173,0.003892767,0.001821355,0.0002210506,0.00275063,0.01385307,0.0003256882,0.008082552,0.0001064593],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922994,0.004535302,0.000372027,0.0002750843,0.00003687969,0.0004487943,0.0007531723,0.00004486484,0.001234482],"genre_scores_gemma":[0.994867,0.001242997,0.0009736969,0.0004774905,0.00008247279,0.0002889467,0.001558765,0.00001028157,0.0004984757],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004638663,"threshold_uncertainty_score":0.02453184,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0795667792310148,"score_gpt":0.2988083256062044,"score_spread":0.2192415463751896,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}